PGK1 and neoplasm: In this study, we found that PGK1 has a negative effect on the survival of lung adenocarcinoma patients, which might be due to PGK1’s mediating interaction between tumor metabolism and immunoediting, suggesting that PGK1 could serve as a potential immune-combination therapy target.